Related Experiment Videos
Hepatitis C infection among drug users attending general practice
1Department of General Practice, University College Dublin, Ireland. walter.cullen@ucd.ie
Irish Journal of Medical Science
|January 1, 2004
Summary
Hepatitis C (HCV) is highly prevalent among Irish injection drug users. Many patients in general practice methadone programs are HCV positive, but a significant number remain untested, highlighting a need for better screening.
Area of Science:
- Public Health
- Infectious Diseases
- Addiction Medicine
Background:
- Hepatitis C virus (HCV) infection is a significant concern among individuals who inject drugs.
- General practitioners (GPs) in Ireland are increasingly involved in providing addiction-related care.
- High HCV prevalence necessitates effective screening strategies within primary care settings.
Purpose of the Study:
- To investigate the prevalence of HCV infection among injecting drug users receiving care in general practices.
- To identify factors associated with HCV infection in this patient population.
- To assess the current HCV testing practices within general practices for patients on methadone maintenance treatment.
Main Methods:
- A retrospective review of patient records was conducted for 571 individuals attending 42 general practices.
- Patients were enrolled in methadone maintenance treatment programs within the Eastern Regional Health Authority (ERHA) area.
- Data on HCV status, testing history, and sources of information were extracted from patient records.
Main Results:
- HCV status was recorded for 67% of the reviewed patient records (380 cases).
- A high prevalence of HCV infection was found, with 73% (276 cases) testing positive.
- Injecting drug use history was the primary factor influencing HCV testing, with no significant difference in prevalence based on the source of HCV status information.
Conclusions:
- A substantial proportion of patients undergoing methadone maintenance treatment in general practice are HCV positive.
- Despite high prevalence, a considerable number of these patients have not undergone HCV testing.
- Barriers to comprehensive HCV screening in this population require further investigation to improve testing rates.